COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
December 2013

20

December
2013

category:

503b Compounding

Novartis Recalls About 5.3 Million Bottles of Sample Drugs

Novartis NOVN.VX in Your Value Your Change Short position has recalled about 5.3 million bottles of blood-pressure medications and other drugs that were provided as free samples to U.S. physicians’ offices, citing potential contamination by a packaging chemical. The bulk of the voluntary recall, which was initiated in the summer, was for about 4.7 million […]

read more

20

December
2013

category:

503b Compounding

Abrams Royal compounding pharmacy recalls all sterile products after adverse event, FDA reports: Food and Drug recalls

CLEVELAND, Ohio– Abrams Royal Compounding Pharmacy, a Dallas-based pharmaceutical product supplier, is recalling all of its unexpired sterile products after an adverse event related to their use, according to a Food and Drug Administration news release. The products include injectable medications, IVs, eye drops, pellet implants, nasal sprays, inhalation solutions and eye ointments, and were […]

read more

20

December
2013

category:

503b Compounding

Drug Shortage Helps Lead to Fall in 2013 Executions

The long-running controversy over lethal-injection drugs helped push the number of executions in 2013 down by about 10%, according to a new report published Thursday. In 2013, nine states were responsible for 39 executions, four fewer than the 43 carried out in both 2012 and 2011, according to an annual study of the death penalty […]

read more